Lin Annie Xianghong, Chan Ging, Hu Yuanjia, Ouyang Defang, Ung Carolina Oi Lam, Shi Luwen, Hu Hao
1International Research Center for Medicinal Administration, Peking University, Beijing, China.
2State Key Laboratory of Quality Research in TCM, Institute of Chinese Medical Sciences, University of Macau, Room 2057, Building N22, Avenida da Universidade, Taipa, Macao.
Chin Med. 2018 Feb 9;13:9. doi: 10.1186/s13020-018-0167-z. eCollection 2018.
Through reviewing the current international market for traditional Chinese medicine (TCM), this paper identified the internationalization challenges for TCM, including unclear therapeutic material basis and mechanism, difficulty of quality control, low preparation level, registration/policy barriers, and shortage of intellectual property. To deal with these challenges, suggestions were given including: (1) product innovation of TCM (study the TCM by using the methods and means of western medicine; innovate the basic theory of TCM; develop TCM health product); (2) standard innovation of TCM; (3) building big data platform of Chinese medicine (big data platform of TCM preparation; big data platform on the quality of TCM).
通过审视当前中医药的国际市场，本文明确了中医药国际化面临的挑战，包括治疗物质基础和作用机制不明确、质量控制困难、制剂水平低、注册/政策障碍以及知识产权短缺等问题。为应对这些挑战，提出了以下建议：（1）中医药产品创新（运用西医的方法和手段研究中医药；创新中医药基础理论；开发中医药健康产品）；（2）中医药标准创新；（3）构建中医药大数据平台（中医药制剂大数据平台；中医药质量大数据平台）。
